␥-Aminobutyric acid type A receptors (GABARs) have long been implicated in mediating ethanol (EtOH) actions, but so far most of the reported recombinant GABAR combinations have shown EtOH responses only at fairly high concentrations (>60 mM). We show that GABARs containing the ␦-subunit, which are highly sensitive to ␥-aminobutyric acid, slowly inactivating, and thought to be located outside of synapses, are enhanced by EtOH at concentrations that are reached with moderate, social EtOH consumption. Reproducible ethanol enhancements occur at 3 mM, a concentration six times lower than the legal blood-alcohol intoxication (driving) limit in most states (0.08% wt͞vol or 17.4 mM). GABARs responsive to these low EtOH concentrations require the GABAR ␦-subunit, which is thought to be associated exclusively with ␣4-and ␣6-subunits in vivo, and the ␤3-subunit, which has recently been shown to be essential for the in vivo anesthetic actions of etomidate and propofol. GABARs containing ␤2-instead of ␤3-subunits in ␣4␤␦-and ␣6␤␦-receptor combinations are almost 10 times less sensitive to EtOH, with threshold enhancement at 30 mM. GABARs containing ␥2-instead of ␦-subunits with ␣4␤ and ␣6␤ are three times less sensitive to EtOH, with threshold responses at 100 mM, a concentration not usually reached with social EtOH consumption. These combined findings suggest that ''extrasynaptic'' ␦-subunit-containing GABARs, but not their ''synaptic'' ␥-subunit-containing counterparts, are primary targets for EtOH.
D
espite the fact that ethanol (EtOH) is the most widely used psychoactive agent, its actions on brain functions are poorly understood. Several types of receptors and channels have been shown to be functionally altered by EtOH, which include Nmethyl-D-aspartate (1) and non-N-methyl-D-aspartate glutamate receptors (2, 3) , serotonin (4), glycine (5, 6) , and GABARs (7, 8) , and G protein-coupled inwardly rectifying K ϩ channels (9, 10) . With a few exceptions (3, (8) (9) (10) (11) (12) , EtOH effects on these targets are seen only at fairly high concentrations (Ն60 mM).
The GABAR, the major inhibitory neurotransmitter receptor, has been a long-time focus for studies on EtOH and anesthetic actions. For example, it has been shown that EtOH at low intoxicating concentrations was able to enhance Cl Ϫ flux in synaptoneurosomes (13, 14) and cultured neurons (15) . However, electrophysiological studies of GABARs in single neurons and recombinant receptors showed current enhancement only at fairly high concentrations (Ͼ50 mM) of EtOH (5, 7, 16) , which now appears to be due to the fact that these studies focused on synaptic and͞or ␥-subunit-containing receptors. It is thought that replacement of the ␥-subunit in the GABAR 2␣-2␤-1␥ pentameric complex by the ␦-subunit changes not only the localization of the receptor from mainly postsynaptic to extrasynaptic, but also leads to up to a 50-fold increase in ␥-aminobutyric acid (GABA) affinity and slower desensitization (17) (18) (19) . These functional properties are consistent with ␣␤␦ GABARs, which are activated by ambient extracellular GABA concentrations (thought to be on the order of 0.5-1 M; ref. 20) . The tonic currents flowing through these channels contrast with synaptic ␣␤␥ GABARs, which open only briefly (Ϸ10 ms) in response to near-saturating amounts (Ն1 mM peak concentration) of GABA released into the synaptic cleft.
Even though ␦-subunits can be forced to form receptors with all ␣-and ␤-subunits tested in recombinant systems (17, 18) , in vivo they appear to associate virtually exclusively with ␣ 4 -(21) and ␣ 6 -subunits (22) . The ␣ 6 -subunit protein is expressed only in cerebellar granule cells, whereas ␣ 4 -subunits have a more widespread distribution and are expressed (with decreasing abundance) in the thalamus, the dentate gyrus, the striatum, the outer layers of the cortex, and at lower levels in other brain areas like the hippocampus. In cerebellar granule cells, the ␦-subunit together with the ␣ 6 -subunit is exclusively extrasynaptic (23) ; and, in neurons expressing the ␣ 4 ͞␦ combination, an extrasynaptic location also seems likely (24) . Consistent with its exclusive association with ␣ 4 -and ␣ 6 -subunits, the distribution of the ␦-subunit revealed by immunostaining has a striking resemblance with ␣ 4 -immunoreactivity in mouse brain (25) , except for the cerebellar granule cell layer where the closely related ␣ 6 -subunit replaces ␣ 4 .
In chronic intermittent EtOH-treated rats, a model for human alcohol-withdrawal syndrome, ␦-subunit protein levels decrease in the hippocampus, whereas ␣ 4 -and ␥ 2 -proteins increase. The changes in synaptic benzodiazepine pharmacology suggest that ␣ 4 -replaces ␣ 1 -subunits in synaptic ␣␤␥-receptors in chronic intermittent EtOH-treated rats (26) . A comparison of ␣ 4 ␤ 3 ␦ and ␣ 4 ␤ 3 ␥ 2 GABARs studied in expression systems revealed that the ␦-subunit-containing receptors showed greater enhancement by etomidate, pentobarbital, propofol, and steroids [tetrahydrodeoxycorticosterone (THDOC) and alphaxalone] than those containing the ␥ 2 -subunit (18, 19, 27, 28) . In knock-in mice, the in vivo actions of etomidate and propofol were almost completely abolished by a point mutation (N256M) in the GABAR ␤ 3 -subunit, which demonstrates that GABARs containing the ␤ 3 -subunit mediate the in vivo effects of these general anesthetics (29) . In contrast, mice containing the etomidate-insensitive N265S mutation in the ␤ 2 -subunit lose sedative but not the anesthetic effects of etomidate (30) .
Here we show that recombinant ␣ 4 ␤ 3 ␦ and ␣ 6 ␤ 3 ␦ GABARs are uniquely sensitive to ethanol, with a dose-response relationship mirroring the well known effects of alcohol consumption on the human brain. Surprisingly, ethanol was much more effective on ␤ 3 -than on ␤ 2 -containing ␣ 4 ␤␦-and ␣ 6 ␤␦-receptors, which demonstrates that the incorporation of the GABAR ␤ 2 -or ␤ 3 -subunits can lead to functionally distinct receptors in recom-binant expression systems. In fact, the EtOH sensitivity was increased only 3-fold by replacing the ␥ 2 -with the ␦-subunit, whereas an almost 10-fold increase was observed by replacement of ␤ 2 with ␤ 3 in the ␣␤␦ GABARs. These findings lead us to propose that extrasynaptic ␣ 4 ␤ 3 ␦-or ␣ 6 ␤ 3 ␦-subunit-containing GABARs are primary targets for EtOH. This hypothesis probably applies also for other GABAR-specific general anesthetics (etomidate, propofol, and steroid anesthetics). The finding that these subtypes of GABAR are likely targets of EtOH action is consistent with their anatomical distribution in brain regions that mediate EtOH effects on behavior, such as the cerebellum (motor coordination), the hippocampal formation (amnesic effects), and the thalamus (sleep-promoting and possibly anesthetic effects). . The ORFs and part of the 3Ј UTRs of the rat ␣ 4 -and ␦-subunits were amplified by PCR and cloned into a vector containing the 5Ј UTR of the Shaker potassium channel. The coding regions of all GABAR cDNA clones used in this study were verified by fluorescent (BigDye3, SigmaAldrich) sequencing. mRNA was transcribed from linearized template plasmids by using the mMESSAGE mMACHINE kits (Ambion, Austin, TX). We purified cRNA transcripts by LiCl precipitation and analyzed transcript quality and concentration by photometry and gel electrophoresis. Oocytes were injected with 0.4 ng of ␣-and ␤-subunit cRNA and 2 ng (in some cases, even 4 ng) of ␦-or ␥ 2 -cRNA. This 5-or 10-fold excess of ␦-and ␥-cRNA over ␣ and ␤ was used to avoid ''contamination'' by functional ␣͞␤-subunit receptors. Currents were measured 3-4 days after oocyte injection for ␥-subunit-containing receptors, whereas oocytes injected with ␦-subunit-containing receptors, because of their apparently low expression levels, had their currents measured 7-8 days after injection.
Methods
Electrophysiology. We measured GABAR currents in oocytes with an Axoclamp 2A amplifier (Axon Instruments, Foster City, CA) in the two-electrode voltage-clamp configuration. Electrodes were filled with 3 M KCl and had resistances between 0.5 and 1.5 M⍀, when measured dipped in the bath solution. The oocyte chamber was continuously perfused with ND96 bath solution (composition, 96 mM NaCl͞2 mM KCl͞1.8 mM CaCl 2 ͞1 mM MgCl 2 ͞5 mM Hepes, pH 7.5) with drugs and treatments mentioned. Solution exchanges were triggered with a programmable valve bank switching a three-way solenoid valve, and bath-volume exchange times were in the range of 1-3 s. Currents were measured at a holding potential (V H ) of Ϫ80 mV (unless indicated otherwise), where GABA applications evoke an inward current in oocytes. Currents and voltages were recorded on a two-channel chart recorder (Soltec 1242, Sun Valley, CA). To minimize voltage-clamp errors, only current responses of Ͻ1 A were considered for analysis. Chart recordings were digitized by using GRAPH DIGITIZATION software (N. Rodionov). GABA, EtOH, and the steroid THDOC (5␤-pregnane-3␣,21-diol-20-one) were obtained from Sigma. THDOC was dissolved in DMSO (10 mM stock solution). Etomidate was the clinical formulation from Bedford Laboratories (Bedford, OH). The curve fits for the GABA doseresponses were generated by the nonlinear sigmoidal doseresponse equation
, where EC 50 is the concentration of drug eliciting a half-maximal response, n is the Hill coefficient, I max is the maximum current, and I is the GABA-evoked current. Values for EC 50 and percent EtOH enhancements were calculated for individual cells and combined to give means with 95% confidence intervals.
Results

Expression and Functional Properties of ␣4␤3␦ or ␣6␤3␦ Receptors in
Xenopus Oocytes. Both GABAR ␣ 4 -and ␦-subunits have been reported to be difficult to express in recombinant systems (27, 31) . In most published studies, the ␣ 4 -subunit and, in some cases, also the ␦-subunit cDNAs (19) were used as chimeras in which the signal sequences and the 5Ј UTRs were replaced by the signal sequence and the 5Ј UTRs of the bovine ␣ 1 GABAR (19, 27, 28, 31) . To prevent expression problems due to inhibitory 5Ј UTRs, we amplified the coding regions of ␣ 4 -and ␦-subunits by PCR and cloned them into an expression vector, thereby replacing upstream noncoding parts of these clones. Rat ␣ 4 -or ␣ 6 -subunits were expressed together with rat ␤ 2 -or ␤ 3 -and ␦-or ␥ 2S (or ␥ 2L )-subunits in Xenopus oocytes. The functional properties of ␦-subunit-containing receptors confirmed previous findings obtained with recombinant receptors in eukaryotic cells (17) (18) (19) 27 ) that ␦-subunit-containing recombinant receptors were Ͼ20 times more sensitive to GABA (than corresponding ␥ 2S -subunitcontaining receptors) and showed slower desensitization. These properties are consistent with their proposed function as extra- GABA dose-responses on GABAR subunit combinations containing either ␣4-or ␣6-subunits, with ␤2-or ␤3-subunits, with and without ␥2S-, ␥2L-, or ␦-subunits. The plots shown are for ␣6␤3␦, ␣6␤3␥2L, ␣1␤3␥2L, ␣6␤3␥2S, and ␣6␤3. GABARs containing ␣4-in place of ␣6-, and ␤2-instead of ␤3-subunits are virtually identical (see Table 1 for EC 50 values). The ␣␤-subunits produce small-current levels and have a fairly low potency for GABA (EC 50 Ϸ 22 M GABA). ␥-Subunitcontaining receptors respond to lower concentrations of GABA (␥ 2S, EC50 Ϸ 18 M GABA; ␣1␤3␥2L, EC50 Ϸ 10 M GABA; ␣6␤3␥2L, Ϸ 8 M GABA). ␦-containing receptors are the most GABA-sensitive with just-detectable responses evident at concentrations as low as 30 nM GABA (EC 50 Ϸ 0.57 M GABA).
synaptic receptors mediating tonic inhibition (20) . Recordings that illustrate the functional differences between receptors containing ␦-subunits versus those containing ␥ 2S -subunits are shown in Fig. 1a . GABA dose-response curves of ␣␤␥ and ␣␤␦ and binary ␣␤ GABARs are shown in Fig. 1b . No significant differences occurred in the GABA dose-response curves when ␣ 4 was replaced by ␣ 6 or when ␤ 2 was replaced by ␤ 3 in ␣␤␥ 2 (EC 50 Ϸ 18 M), ␣␤␦ (EC 50 Ϸ 0.57 M), or ␣␤ (EC 50 Ϸ 22 M) subunit combinations. The fact that receptors containing ␣ 4 -subunits with a modified 5Ј-UTR expressed current levels similar to those containing ␣ 6 -subunits suggests that the 5Ј untranslated region in the ''native'' ␣ 4 -subunit is responsible for the reported poor expression in recombinant expression systems rather than inefficient processing of the native ␣ 4 -subunit protein.
GABARs Containing the ␦-Subunit at Saturating GABA Concentrations:
GABA as a Partial Agonist. In all receptor combinations tested, GABA-evoked peak currents from ␥ 2S -containing receptors were much larger than those from corresponding ␦-subunitcontaining receptors when measured at the same time after injection. This finding held true despite our efforts to improve expression by modifying the 5Ј untranslated region in the ␦-subunit cDNA. However, smaller currents are not due to the fewer channels expressed, because coapplication of a high concentration (1 M) of the neurosteroid THDOC together with GABA increased current levels in ␣ 4 ␤ 2 ␦-receptors about 5-fold at all GABA concentrations tested (Fig. 2) , consistent with the reported effects of THDOC on ␣ 6 ␤ 3 ␦ (18) and ␣ 4 ␤ 3 ␦ (19). Because the efficacy of etomidate is much greater at ␣ 4 ␤ 3 ␦ versus ␣ 4 ␤ 3 ␥ 2 GABARs (19), we tested whether etomidate would increase peak current responses on ␣ 6 ␤ 3 ␦ GABARs in oocytes. Etomidate (from 0.1 to 1000 M) coapplied with a close to saturating concentration of GABA (10 M or EC 95 ; see Fig.  1a ) led to a dramatic dose-dependent enhancement of peak current responses (Fig. 2b) . At the most effective concentration of etomidate (100 M), peak current increases about 20-fold. This result is probably an underestimation because of the fairly slow perfusion around the oocyte, which tends to obscure peak current responses at desensitizing receptors. This finding is the likely explanation for the lower peak current responses with 10 M GABA ϩ 1,000 M etomidate (Fig. 2b ) and for the decrease in peak currents 10 M GABA ϩ 1 M THDOC (Fig. 2a) . This dramatic enhancement of peak GABA currents (even at saturating GABA concentrations) by etomidate and THDOC suggests that the low-current levels we observe in ␦-subunitcontaining receptors are caused by GABA being a partial agonist on ␣␤␦ GABAR, rather than by a problem with expression (i.e., the number of functional channels formed). (32), and GABARs have long been implicated in mediating EtOH effects (7), we tested EtOH on ␦-subunit-containing GABARs under the same conditions as etomidate (coapplication of EtOH with 10 M GABA). With the ␣ 6 ␤ 3 ␦ GABARs, we saw justdetectable increases at 3 mM and a 2-fold increase in peak currents at 1 M EtOH (Fig. 2c) . In the range from 0 to 300 nM etomidate, the amount of peak current enhancement coincides with that seen with 0 -300 mM EtOH at ␣ 6 ␤ 3 ␦-subunitcontaining GABARs (compare Fig. 2b with Fig. 2c) .
To further characterize EtOH responses, we tested at a GABA concentration that produced 20% of peak currents (EC 20 ) for each subunit combination (300 nM for ␣␤␦, 10 M for ␣␤␥, and 30 M for ␣␤ GABAR combinations; see Fig. 1b ). Measuring at a nonsaturating EC 20 GABA concentration is reasonable for extrasynaptic GABARs, because they operate at usually nonsaturating GABA concentrations.
EtOH effects were recorded by using short ethanol coappli- 
Values were calculated for each individual cell and represent the arithmetic mean Ϯ SEM from a number (n) of various cells. cation (from 1 to 300 mM) with EC 20 GABA concentrations to evoke a peak current, with recovery periods of at least 40 s between applications (Fig. 3 Inset) . The peak responses were plotted as an increase over peak currents with EC 20 GABA applications alone (Fig. 3a) . GABARs composed of ␣ 6 ␤ 3 ␦ and ␣ 4 ␤ 3 ␦ showed the highest EtOH sensitivity and had a similar enhancement at low EtOH concentrations, whereas at concentrations of Ͼ10 mM EtOH, ␣ 6 ␤ 3 ␦-receptors showed greater enhancement by EtOH than ␣ 4 ␤ 3 ␦-receptors. Receptors containing the ␤ 2 -subunit were much less sensitive than the corresponding ␤ 3 -containing receptors at low EtOH concentrations [threshold responses at 30 mM (Fig. 3a) ] but not at very high (300 mM) EtOH concentrations. Receptors containing the ␥ 2 -subunit showed significant EtOH activation starting at a concentration of 100 mM, and GABARs composed of only ␣␤-subunits were almost completely insensitive, even at 300 mM EtOH (see Table  1 for percent EtOH increases for each subunit combination).
In addition to EtOH effects evaluated by GABA͞EtOH coapplication, we used a protocol where we tried to mimic the physiological modus operandi of extrasynaptic GABA receptors (Fig. 3b) . This protocol involved the prolonged application of 300 nM GABA (i.e., EC 20 ) to the oocyte, where currents relaxed to the steady-state activation level to which increasing concentrations of EtOH (in 300 nM GABA) were applied (Fig. 3b) . Similar to results seen in the GABA-EtOH coapplication protocol, we saw the threshold current enhancement at 30 mM EtOH with ␣ 4 ␤ 2 ␦, whereas with the ␣ 6 ␤ 3 ␦ or ␣4␤ 3 ␦ combinations, the threshold response was observed at 3 mM, a concentration almost six times lower than the human blood-alcohol legal driving limit of 17.4 mM. Although the EtOH potency was similar under both measuring conditions, the absolute current enhancement by EtOH (efficacy) was about twice as large when GABA͞EtOH was coapplied to nondesensitized receptors as in the EtOH application under steady-state conditions. This finding suggests that EtOH responsiveness may be diminished during the prolonged presence of GABA, possibly because of slowly populated states of the receptor with diminished EtOH sensitivity. It is interesting that EtOH responses in the presence of 300 nM GABA seem to have their own, only weakly dose-dependent, desensitization (see Fig. 3b ).
Discussion An Extrasynaptic GABAR Subunit Combination Is Highly Sensitive to
Ethanol. EtOH has been shown to enhance ␥-subunit-containing GABARs and glycine receptors in recombinant systems and in slice recordings to increase inhibitory postsynaptic potential͞ inhibitory postsynaptic current (IPSP͞C) decay times. However, in most studies the concentrations needed (Ͼ40 mM) to show significant GABAR current enhancement are beyond the usual blood-ethanol concentrations reached during human alcohol consumption and would be potentially life-threatening (33) . The median lethal blood-alcohol concentration in Finnish people was reported to be 0.33% or 72 mM (33) . It seems unlikely, therefore, that synaptic receptors are primary EtOH responders, but they may contribute to EtOH toxicity at high concentrations. We confirm the relative EtOH insensitivity of ␥-subunit-containing GABARs, which in our hands showed just-detectable EtOH enhancement at 100 mM but not at 30 mM, whereas GABARs containing the ␣ 4 ␤ 2 ␦-or ␣ 6 ␤ 2 ␦-subunits are about three times more sensitive. Most surprisingly, replacement of the ␤ 2 -with the ␤ 3 -subunit increased the EtOH sensitivity 10-fold, showing that ␤-subunit isoforms can lead to functional differences in recombinant GABARs. It is likely that the stimulation of GABA- 20 values of the various subunit combinations. ␣␤␦-Subunits show the largest enhancement, ␤3-containing receptors being the most sensitive. ␥-containing GABAR currents show significant potentiation only at 100 mM EtOH, and ␣␤-subunits seem to be completely insensitive. The plots shown are for ␣6␤3␦ (ࡗ), ␣4␤3␦ (E), ␣4␤2␦ (ϫ), ␣6␤3␥2L (OE), ␣6␤3␥2S (ƒ), and ␣6␤3 (s) (n ϭ 13, 12, 15, 10, 9, and 5, respectively); the remaining combinations with ␦, ␥2S, or ␥2L or neither were virtually indistinguishable from the subunits represented (see Table 2 for pooled EtOH-response values). (b) EtOH effects on tonically activated receptors. Replacement of ␤2-with ␤3-subunits in ␣4␤␦ or ␣6␤␦ GABARs leads to an almost 10-fold increase in EtOH sensitivity. EtOH response (from 3 to 300 mM) on ␣4␤2␦-, ␣4␤3␦-, ␣6␤2␦-, and ␣6␤3␦-containing GABARs activated by steadystate 300 nM GABA (ϷEC 30). Values are increase of GABA EC20 peak responses in percent Ϯ SD at the indicated EtOH concentrations with different subunit combination. Values for ␣4-and ␣6-receptors were pooled, and all those for ␤2-and ␤3-receptors in ␣␤␥ and ␣␤ combinations. Asterisks indicate significant differences (P Ͻ 0.005); e.g., a significant difference occurs in EtOH enhancement between ␣␤␥ and ␣␤, but no significant difference (P Ͼ 0.05) was seen between ␣␤2␦ and ␣␤␥ (Student's paired t test).
dependent Cl Ϫ uptake into synaptoneurosomes by fairly low concentrations of EtOH in early studies (13) might have been due to the presence of extrasynaptic ␣ 6 ␤ 3 ␦-or ␣4␤ 3 ␦-subunitcontaining receptors in these preparations and that the failure to see EtOH effects at such low concentrations in many preparations and laboratories since that time may be explained by research focusing on recombinant receptors containing ␥-subunits and in vivo studies on synaptic GABARs. Apart from real (with the ␣ 4 -subunit) or apparent difficulties (because GABA being only a partial agonist with low efficacy) to express ␦-subunit-containing receptors in recombinant systems, ␦-subunitcontaining receptors may not have received attention because they make up only a fairly small fraction of GABARs in the mammalian brain, with each ␣ 4 ␤ 3 ␦ and ␣ 6 ␤ 3 ␦ estimated to contribute Ͻ5% to the total number of GABARs (34) .
While this work was in progress, it was reported that ␣ 4 ␤ 2 ␦-receptors expressed in Xenopus oocytes are enhanced by surprisingly low EtOH concentrations; threshold activation was reported to occur at 0.1 mM (11), a concentration 300 times lower than we observed with ␣ 6 ␤ 2 ␦ or ␣4␤ 2 ␦ GABARs. These workers also showed a bell-shaped dose-response with the EtOH effect declining at 10 mM, and report (in their supporting data) that ␣ 4 ␤ 3 ␦-receptors, which were the most sensitive to EtOH in our hands, did not give functional expression in oocytes. In addition, the GABA-EC 20 for their ␣ 4 ␤ 2 ␦-receptors is almost 10 times lower than in our experiments and reported in the literature (19, 27) . It remains to be determined what accounts for these discrepancies. One possibility is the differences in the cDNAs used, particularly the functionality of their ␣ 4 -subunit.
Tonic inhibitory K ؉ and Cl ؊ Currents Modulated by Anesthetics and
Ethanol: Mutant Mice and Compensatory Mechanisms. Extrasynaptic GABARs are high-affinity receptors activated by ambient GABA concentrations (thought to be in the range of 0.5-1 M), and their activation usually leads to a decrease in neuronal excitability. Functionally, extrasynaptic GABA receptors are similar to the ''background K ϩ channels,'' which comprise two main families: the two pore K ϩ channels (TREK and TASK) and G protein-coupled inward rectifier K ϩ (GIRK) channels (see Fig. 4 ). These K ϩ channels are candidate targets for actions of volatile anesthetics (35, 36) .
GABAR ␣ 6 -subunit knock-out mice not only lack ␣ 6 -but also ␦-subunit protein in cerebellar granule cells (22) , and lose ''tonic'' GABAR currents (37) . Cerebellar granule cells compensate for this loss of extrasynaptic GABA receptors in ␣ 6 (Ϫ͞Ϫ) mice by increasing their background leak conductance by expressing K ϩ channels with properties characteristic for the two-pore-domain K ϩ channel TASK1 (37) . The up-regulation of TASK1 and possibly other proteins may explain why ␣ 6 (Ϫ͞Ϫ) mice do not show motor deficits or changes in response to EtOH or other general anesthetics, including barbiturates (38) . Although in ␤ 3 -subunit knock-out mice a significant reduction occurred in etomidate sensitivity of loss of righting reflex (39), the fairly moderate reduction is surprising given that mice carrying a single knock-in point mutation in the ␤ 3 -subunit (N256M, which makes ␤ 3 -containing receptors insensitive to etomidate in vitro) essentially eliminates etomidate-and propofol-induced anesthesia (40) .
Consistent with the notion that ␦ GABARs are important targets for anesthetics, mice globally lacking the GABAR ␦-subunit show not only a reduction in sensitivity to neurosteroid anesthetics but also a reduction in etomidate sensitivity (41) . ␦(Ϫ͞Ϫ) mice also show defects in their behavioral responses to ethanol, with reduced ethanol consumption, attenuated withdrawal from chronic ethanol exposure, and reduced seizureprotective effects of ethanol (42) . However, these mice still have normal anxiolytic and hypothermic EtOH responses and develop both chronic and acute tolerance. Taken together, compensatory homeostatic mechanisms may mask EtOH effects in straight ␣ 6 and ␤ 3 knock-out mice and some of the EtOH effects in ␦-subunit knock-out animals. Based on our findings, it may be interesting to reevaluate EtOH and anesthetic effects in these knock-out animals.
We found that the ␤ 3 -subunit is required for high EtOH sensitivity of ␣ 6 ␦-or ␣ 4 ␦-subunit-containing GABARs and, therefore, if these receptors are important for in vivo EtOH effects, it would be expected that the ␤ 3 -subunit may be assembled in extrasynaptic ␣ 6 ␤␦ or ␣ 4 ␤␦ GABARs preferentially over other ␤-subtypes. The fact that the GABAR ␤ 3 (N256M) mutation in mice produces an almost complete loss of anesthetic etomidate's effects in vivo and almost perfectly mirrors the loss of etomidate effect of this mutation in recombinant systems is surprising because ␤ 2 (but not ␤ 1 )-subunit-containing receptors would be expected to be sensitive to etomidate in vivo as well (29, 40, 43) . In marked contrast to the ␤ 3 (N256M) mice, the etomidate-insensitive ␤ 2 (N265S) mutant, when introduced into knock-in mice, does not abolish anesthesia, but eliminates most of the sedative effects of etomidate (30) . An exclusive association of extrasynaptic ␣ 4 ␦ (and ␣ 6 ␦) with ␤ 3 -subunits (but not ␤ 2 -or ␤ 1 -subunits) to form the etomidate-sensitive anesthetic GABARs would provide a plausible explanation for the almost complete loss of anesthetic etomidate effects in the ␤ 3 (N256M) Fig. 4 . Synaptic versus extrasynaptic receptors. Synaptic receptors (shown is the most prevalent ␣1␤2␥2 synaptic GABARs) respond to saturating GABA (Ͼ1 mM peak GABA concentrations) and show high efficacy but fairly low potency (45) . In contrast, extrasynaptic receptors (composed of ␣4␦-or ␣6␦-and most likely ␤3-subunits) are activated by persistent and usually nonsaturating ambient GABA concentrations (0.5-1 M), and, even at saturating GABA concentrations, are characterized by low-current levels (high-potency, lowefficacy receptors). We suggest a model where EtOH and other anesthetics lead to an increase in GABA efficacy (increase in open probability and͞or possibly single-channel conductance), which leads to increased Cl Ϫ current. A massive increase in GABA-activated Cl Ϫ conductance by anesthetics could completely silence neurons expressing ␦-subunit-containing GABARs, thereby producing anesthesia. The activation of extrasynaptic GABARs is functionally equivalent to activation of background K ϩ channels. G protein-coupled inwardly rectifying K ϩ (GIRK) channels have been shown to respond to fairly low concentrations of EtOH (3, 4) and may mediate EtOH analgesic actions (5) . GIRK channels may also contribute to the anesthetic actions of volatile anesthetics (48, 49) . The two-pore K ϩ channels, TASK1 and TREK, are likely targets for volatile anesthetics (35, 36, 50, 51) . The functional similarity between extrasynaptic GABARs and two-pore K ϩ channels is supported by the finding that, in cerebellar granule cells, a background potassium channel (most likely TASK1), compensates for the loss of extrasynaptic GABARs in mice lacking the GABAR ␣6-subunit (37).
mice. The depth and duration of sedation by etomidate and other GABAR-specific anesthetics is augmented by their actions on synaptic ␣␤ 2 ␥-subunit-containing receptors (leading to increased IPSP͞C decay times), and these effects are drastically reduced in the ␤ 2 (N265S) mutant mice (30) . Along those lines, GABARs composed of ␣ 1 ␤ 2 ␥ 2 -subunits are thought to represent Ϸ50% of all GABARs in mammalian brain, and, because GABAR ␤ 2 -and ␤ 3 -subunits are each estimated to constitute Ϸ50% of total ␤-subunits (the ␤ 1 -subunit is a rare subunit) (34) , most GABARs other than primarily synaptic ␣ 1 ␤ 2 ␥ 2 GABARs must contain the ␤ 3 -subunit. These GABARs would include synaptic ␣ 2 -and ␣ 3 -containing receptors and probably most extrasynaptic receptors.
GABA as a Partial Agonist: Ethanol and Anesthetics Increase Efficacy.
Oocytes expressing ␦-subunit-containing receptors have only low-current levels. Although we cannot exclude that singlechannel conductance increases with EtOH, etomidate, and THDOC (44), the 20-fold increase of GABA current produced by etomidate at saturating GABA concentrations is probably due to a low open probability with GABA alone. This low open probability provides an explanation for the apparent ''expression problems'' of ␦-subunit-containing receptors. Therefore, GABA has only poor efficacy at ␦-subunit-containing receptors and might be considered a partial agonist. The dramatic increase in GABA peak currents by anesthetics suggests that they may convert the partial agonist GABA into a full agonist at this receptor subtype.
Although GABAR-specific anesthetics (particularly etomidate) are more efficacious on ␦-subunit-containing receptors than on ␥-subunit-containing receptors (19), they also activate ␥ 2 -containing (generally synaptic) GABARs [usually evaluated at nonsaturating (EC 10 or EC 50 ) GABA concentrations]. The fact that inhibitory postsynaptic currents (and potentials) rarely show peak increases in response to GABAR-enhancing agents (benzodiazepine and anesthetics), but rather a slowed IPSP͞C decay, suggests that (i) synaptic GABARs are usually activated by saturating (Ϸ1 mM) GABA concentrations in the synaptic cleft and (ii) GABA is a full agonist at these receptors and leads to a nearly full receptor activation, which leaves only little or no room for peak current increases (26, (45) (46) (47) . However, the stabilization of receptors in the open state by anesthetics may lead to the observed slowing of IPSP͞C decay due to slower closing rates and͞or decreased desensitization rates. It is therefore likely that the sedative benzodiazepine-like effects of GABAR-specific anesthetics are mediated by effects on synaptic, ␥ GABARs (see Fig. 4 ).
In summary, we show that GABARs composed of ␣ 4 ␤ 3 ␦-and ␣ 6 ␤ 3 ␦-subunits, which others have shown to be located extrasynaptically, are activated by low concentrations of EtOH, and that the ␤ 3 -subunit is required for effects of EtOH at these low concentrations. Previous studies apparently have not noted this potent action because ␦-subunits were not studied in recombinant systems, and synaptic currents, generated by ␥ 2 -rather than ␦-containing GABARs, have been emphasized in neuronal studies. Because the same receptors that we find to be sensitive to low concentrations of EtOH also show dramatic enhancement with general anesthetics, we propose and argue for a simple model (Fig. 4) , where extrasynaptic receptors are the primary targets for EtOH, other GABAR-specific anesthetics, and steroids. Stell et al. ‡ have shown that neurosteroids enhance tonic conductance generated by ␦-containing GABARs. It will be important to determine whether EtOH (and other GABARspecific anesthetics) enhance extrasynaptic currents at comparable concentrations in neurons expressing ␣ 4 ␤␦-and ␣ 6 ␤␦-receptors (but not in those neurons that do not) and if this action mediates physiological effects. We thank Dr. Tom Otis for discussions and critical comments on the manuscript and Bob Silverman for expert technical help. This work was supported by National Institutes of Health Grants NS35985, AA07680, and GM58448.
